Bath scientists stabilise vaccine proteins with ensilication
A new system for delivering vaccines to children in low-income nations has taken a vital step forward, thanks to groundbreaking work at the University of Bath
Vaccines are notoriously difficult to transport to remote or dangerous places, as they spoil when not refrigerated. Formulations are safe between 2°C and 8°C, but at other temperatures the proteins start to unravel, making the vaccines ineffective. As a result, millions of children around the world miss out on life-saving inoculations.
However, scientists have now found a way to prevent warmed-up vaccines from degrading. By encasing protein molecules in a silica shell, the structure remains intact even when heated to 100°C, or stored at room temperature for up to three years.
The technique for tailor-fitting a vaccine with a silica coat – known as ensilication – was developed by a Bath team in collaboration with the University of Newcastle. This pioneering technology was seen to work in the lab two years ago, and now it has demonstrated its effectiveness in the real world too.
The researchers explain the significance of their findings
In their latest study, published in the journal Scientific Reports, the researchers sent both ensilicated and regular samples of the tetanus vaccine from Bath to Newcastle by ordinary post (a journey time of over 300 miles, which by post takes a day or two). When doses of the ensilicated vaccine were subsequently injected into mice, an immune response was triggered, showing the vaccine to be active. No immune response was detected in mice injected with unprotected doses of the vaccine, indicating the medicine had been damaged in transit.
Dr Asel Sartbaeva, who led the project from the University of Bath’s Department of Chemistry, said: “This is really exciting data because it shows us that ensilication preserves not just the structure of the vaccine proteins but also the function – the immunogenicity.”
“This project has focused on tetanus, which is part of the DTP (diphtheria, tetanus and pertussis) vaccine given to young children in three doses. Next, we will be working on developing a thermally-stable vaccine for diphtheria, and then pertussis. Eventually we want to create a silica cage for the whole DTP trivalent vaccine, so that every child in the world can be given DTP without having to rely on cold chain distribution.”
Cold chain distribution requires a vaccine to be refrigerated from the moment of manufacturing to the endpoint destination.
Silica is an inorganic, non-toxic material, and Dr Sartbaeva estimates that ensilicated vaccines could be used for humans within five to 15 years. She hopes the technology to silica-wrap proteins will eventually be adopted to store and transport all childhood vaccines, as well as other protein-based products, such as antibodies and enzymes.
“Ultimately, we want to make important medicines stable so they can be more widely available,” she said. “The aim is to eradicate vaccine-preventable diseases in low income countries by using thermally stable vaccines and cutting out dependence on cold chain.”
Currently, up to 50% of vaccine doses are discarded before use due to exposure to suboptimal temperatures. According to the World Health Organisation (WHO), 19.4 million infants did not receive routine life-saving vaccinations in 2018.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- "No legal compulsion"; Centre says govt can't be held liable for deaths due to COVID vaccines
In the affidavit filed on November 23, the Health Ministry said that though the government strongly encourages all eligible persons to take vaccine in public interest, there is no legal compulsion for ...
- Germany urges China to end lockdowns with Western vaccines
Warning comes as analysis predicts millions of deaths among China's unvaccinated population if the zero Covid approach is lifted now ...
- China’s zero-COVID strategy makes no sense and its homegrown vaccines are not ‘particularly effective,’ says Fauci
CORONAVIRUS UPDATE Widespread protests across China over the government’s zero-COVID policy dominated pandemic headlines Monday, with Anthony Fauci, President Joe Biden’s chief medical ...
- Biden's Mystifying Failure to Back Next-Generation Vaccines | Opinion
As Americans head into their third full winter accompanied by COVID-19, the Biden administration continues to disappoint in its management of the pandemic.
- EU funds 5 million for clinical trials of Ebola vaccines and treatments in Uganda
The European Commission announced on Monday that 5 million euros will be allocated from the EU coffers to pay for clinical trials of vaccines and treatments against the SUDV strain of Ebola, against ...
Go deeper with Google Headlines on:
[google_news title=”” keyword=”vaccines” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
- Immorna cleared for mRNA-based Covid-19 vaccine study
Immorna says the FDA has cleared its IND application for a study of JCXH-221, an mRNA vaccine against SARS-CoV-2 infection and diseases.
- Immorna Receives IND Clearance to Conduct a Phase 1/2 Study of JCXH-221, a Broadly Protective mRNA-Based COVID-19 Vaccine
Immorna, a rapidly expanding biotechnology company, focusing on the development of multi-platform RNA-based therapeutics and vaccines, today announced that the U.S. Food and Drug Administration (FDA) ...
- A New Way to Create Thermally Stable High-Entropy Alloys
This novel stabilizing strategy opens a new pathway to design novel thermally stable chemically complex alloys for various engineering fields in the future. Nanoparticle-strengthening ...
- New technique to create thermally stable, high-entropy alloys
This novel stabilizing strategy opens a new pathway to designing novel thermally stable chemically complex alloys for various engineering fields in the future. Nanoparticle-strengthening ...
- CityU materials scientists find a new way to create thermally stable high-entropy alloys
This novel stabilising strategy opens a new pathway to design novel thermally stable chemically complex alloys for various engineering fields in the future. Nanoparticle-strengthening technology ...
Go deeper with Google Headlines on:
[google_news title=”” keyword=”thermally-stable vaccine” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]